Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Supportive Care in Cancer
Published in: Supportive Care in Cancer 10/2019

01-10-2019 | Care | Original Article

A cross-sectional population-based survey looking at the impact of cancer survivorship care plans on meeting the needs of cancer survivors in the posttreatment stage

Authors: Soleil Chahine, Robin Urquhart

Published in: Supportive Care in Cancer | Issue 10/2019

Login to get access

Abstract

Purpose

The purpose of this study was to determine the impact of receiving a survivorship care plan (SCP) on meeting cancer survivors’ overall, informational, physical, emotional, and practical needs. Since the recommendation for implementation of SCPs, there have been numerous studies on their effectiveness with mostly inconclusive results.

Methods

All Nova Scotia survivors meeting specific inclusion and exclusion criteria were identified from the Nova Scotia Cancer Registry and sent the 83-item survey to assess experiences and needs across five domains (overall, informational, physical, emotional, and practical). Descriptive statistics (frequencies, percentages) and chi-square analyses were used to examine and report survey findings.

Results

The response rate was 44.6%, with 1514 respondents. SCPs were significantly associated (p < 0.00001) with receiving timely help and support to meet survivors’ overall, informational, physical, emotional, and practical needs posttreatment. For the most part, survivors’ clinical characteristics, such as cancer type, time since treatment, chronic comorbidities, and metastases, did not result in differences among the five outcomes.

Conclusions

Those who received a SCP reported higher agreement on all five outcomes in comparison to those who did not receive a SCP. Further work should evaluate the delivery of SCPs and the components of SCPs that are most likely to contribute to positive survivor outcomes.
Literature
1.
Miller KD, Siegel RL, Lin CC, Mariotto AB, Kramer JL, Rowland JH et al (2016) Cancer treatment and survivorship statistics, 2016. Am J Clin Oncol 66(4):271–289
2.
Canadian Cancer Society’s Advisory Committee on Cancer Statistics (2017) Canadian Cancer Statistics. Can Cancer Soc 2017:1–132
3.
Miller KD, Pandey M, Jain R, Mehta R (2015) Cancer survivorship and models of survivorship care: a review. Am J Clin Oncol 38(6):627–633CrossRefPubMed
4.
Hewitt M, Greenfield S, Stovall E, Policy NC. (2005) From cancer patient to cancer survivor: lost in translation. Committee on cancer survivorship: improving quality care and quality of life, national cancer policy board; Washington, DC: National Academies Press. 150–156
5.
Van De Poll-franse LV, Nicolaije KAH, Ezendam NPM, Nicolaije KAH, Ezendam NPM (2017) The impact of cancer survivorship care plans on patient and health care provider outcomes: a current perspective. Acta Oncol (Madr) 56(2):134–138CrossRef
6.
Lagrandeur W, Armin J, Howe CL, Ali-akbarian L (2018) Survivorship care plan outcomes for primary care physicians, cancer survivors, and systems: a scoping review. J Cancer Surviv 12:334–347CrossRefPubMed
7.
Jacobsen PB, Derosa AP, Henderson TO, Mayer DK, Moskowitz CS, Electra D et al (2018) Systematic review of the impact of cancer survivorship care plans on health outcomes and health care delivery. J Clin Oncol 36(20):2088–2100CrossRefPubMedPubMedCentral
8.
Klemanski DL, Browning KK, Kue J (2016) Survivorship care plan preferences of cancer survivors and health care providers: a systematic review and quality appraisal of the evidence. J Cancer Surviv 10(1):71–86CrossRefPubMed
9.
Nicolaije KAH, Ezendam NPM, Vos MC, Pijnenborg JMA, Boll D, Boss EA, Hermans RHM, Engelhart KCM, Haartsen JE, Pijlman BM, van Loon-Baelemans IEAM, Mertens HJMM, Nolting WE, van Beek JJ, Roukema JA, Zijlstra WP, Kruitwagen RFPM, van de Poll-Franse LV (2015) Impact of an automatically generated cancer survivorship care plan on patient-reported outcomes in routine clinical practice: longitudinal outcomes of a pragmatic, cluster randomized trial. J Clin Oncol 33(31):3550–3559CrossRefPubMed
10.
Kvale EA, Huang CHS, Meneses KM, Demark-Wahnefried W, Bae S, Azuero CB, Rocque GB, Bevis KS, Ritchie CS (2016) Patient-centered support in the survivorship care transition: outcomes from the patient-owned survivorship care plan intervention. Cancer 122(20):3232–3242CrossRefPubMed
11.
Keesing S, Mcnamara B, Rosenwax L (2015) Cancer survivors’ experiences of using survivorship care plans: a systematic review of qualitative studies. J Cancer Surviv 9:260–268CrossRefPubMed
12.
Birken SA, Urquhart R, Munoz-Plaza C, Zizzi AR, Haines E, Stover A, Mayer DK, Hahn EE (2018) Survivorship care plans: are randomized controlled trials assessing outcomes that are relevant to stakeholders? J Cancer Surviv 12(4):495–508CrossRefPubMedPubMedCentral
13.
Beckjord EB, Reynolds KA, van Londen G, Burns R, Singh R, Arvey SR et al (2014) Population-level trends in posttreatment cancer survivors’ concerns and associated receipt of care: results from the 2006 and 2010 LIVESTRONG surveys. J Psychosoc Oncol 32(2):125–151CrossRefPubMedPubMedCentral
14.
Hodgkinson K, Butow P, Hunt G, Pendelbury S, Hobbs K, Lo S et al (2007) The development and evaluation of a measure to assess cancer survivors’ unmet supportive care needs: the CaSUN (cancer survivors’ unmet needs measure). Psychooncology 16:796–804CrossRefPubMed
15.
Boekhout AH, Maunsell E, Pond GR, Julian JA, Coyle D, Levine MN et al (2015) A survivorship care plan for breast cancer survivors: extended results of a randomized clinical trial. J Cancer Surviv 9(4):683–691CrossRefPubMed
16.
Maly RC, Liang L-J, Liu Y, Griggs JJ, Ganz PA (2017) Randomized controlled trial of survivorship care plans among low-income, predominantly Latina breast cancer survivors. J Clin Oncol 35(16):1814–1821CrossRefPubMedPubMedCentral
17.
Smith K, Tolbert E, Hannum S, Radhakrishnan A, Zorn K, Blackford A et al (2016) Comparing web-based provider-initiated and patient-initiated survivorship care planning for cancer patients: a randomized controlled trial. JMIR Cancer 2(2):e12CrossRefPubMedPubMedCentral
18.
Moore A, Carlson A, Kornhauser N, Schneider SE, Andreopoulou E, Cigler T, Vahdat LT, Webster G, Guthrie W (2018) Breast cancer survivorship care plan: patient satisfaction with a web-based application. J Clin Oncol 36(7):50CrossRef
19.
Birken SA, Raskin S, Zhang Y, Lane G, Zizzi A, Pratt-Chapman M. (2018) Survivorship care plan implementation in US cancer programs: a national survey of cancer care providers. J Cancer Educ
Metadata
Title
A cross-sectional population-based survey looking at the impact of cancer survivorship care plans on meeting the needs of cancer survivors in the posttreatment stage
Authors
Soleil Chahine
Robin Urquhart
Publication date
01-10-2019
Publisher
Springer Berlin Heidelberg
Keyword
Care
Published in
Supportive Care in Cancer / Issue 10/2019
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-019-04685-5

Other articles of this Issue 10/2019

Supportive Care in Cancer 10/2019 Go to the issue

Review Article

Biological predictors of chemotherapy-induced peripheral neuropathy (CIPN): MASCC neurological complications working group overview

Original Article

A feasibility study examining the impact of yoga on psychosocial health and symptoms in pediatric outpatients receiving chemotherapy

Special Article

Development of the MASCC/ISOO clinical practice guidelines for mucositis: an overview of the methods

Review Article

Deglutition disorders as a consequence of head and neck cancer therapies: a systematic review and meta-analysis

Original Article

Effectiveness of exercise-based rehabilitation on functional capacity and quality of life in head and neck cancer patients receiving chemo-radiotherapy

Original Article

Screening for clinical insomnia in cancer patients with the Edmonton Symptom Assessment System-Revised: a specific sleep item is needed
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits